Sei Investments CO Adverum Biotechnologies, Inc. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$10.3 - $21.64 $191,497 - $402,330	-18,592 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$8.53 - $25.64 $158,589 - $476,698	18,592 New	18,592 $388,000
Q3 2019 Nov 12, 2019	SELL	$5.24 - $15.89 $235,333 - $713,635	-44,911 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.1 - $11.89 $229,046 - $533,991	44,911 New	44,911 $534,000

3.6M

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $684M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.